phenylephrine-hydrochloride and Hypopharyngeal-Neoplasms

Although office-based transnasal esophagoscopy has been investigated extensively, a cost analysis is still lacking. We performed a cost analysis combined with feasibility study for two diagnostic processes: patients with globus pharyngeus and/or dysphagia, and hypopharyngeal carcinoma.. Prospective cohort study.. Forty-one procedures were performed, of which 35 were fully completed. The procedure was well tolerated with mild complaints such as nasal or pharyngeal pain and burping. Four complications occurred: two minor epistaxis and two vasovagal reactions. In patients with globus pharyngeus and/or dysphagia, transnasal esophagoscopy resulted in a cost saving of €94.43 (p 0.026) per procedure, compared to our regular diagnostic process. In patients with suspicion of hypopharyngeal carcinoma, cost savings were €831.41 (p 0.000) per case.. Cost analysis showed that office-based transnasal esophagoscopy can provide significant cost savings for the current standard of care. Furthermore, this procedure resulted in good patient acceptability and few complications.

Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Cost Savings; Cost-Benefit Analysis; Deglutition Disorders; Esophagoscopy; Feasibility Studies; Female; Health Care Costs; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Netherlands; Nose; Pharyngeal Diseases; Prospective Studies

Topics: Cervical Vertebrae; Humans; Hypopharyngeal Neoplasms; Neck; Nose; Osteoradionecrosis; Pharynx

Topics: Biopsy; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Humans; Hypopharyngeal Neoplasms; Lymph Nodes; Male; Middle Aged; Neck Dissection; Nose; Skin Neoplasms